TARO logo

Taro Pharmaceutical Industries (TARO) Free Cash Flow

Annual FCF

$70.34 M
+$58.43 M+490.92%

31 March 2024

1-Year Change

+490.92%
TARO annual free cash flow is up +490.92% year-on-year

3-Year Change

+145.78%
TARO annual free cash flow is up +145.78% over the past 3 years

All-time High

$401.71 M
TARO annual free cash flow is currently -82.49% below its historical high of $401.71 million

Annual FCF Formula

Cash From Operations − CAPEX
Annual CFO$124.56 M
TARO annual cash flow from operations is $124.56 million
Annual CAPEX$54.22 M
TARO annual capital expenditures is $54.22 million

TARO Free Cash Flow Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly FCF

$32.45 M
+$36.00 M+1013.23%

31 March 2024

1-Year Change

-19.9%
TARO quarterly free cash flow is down -19.9% year-on-year

3-Year Change

+160.06%
TARO quarterly free cash flow is up +160.06% over the past 3 years

All-time High

$207.81 M
TARO quarterly free cash flow is currently -84.39% below its historical high of $207.81 million
Quarterly CFO$38.34 M
TARO quarterly cash flow from operations is $38.34 million
Quarterly CAPEX$5.89 M
TARO quarterly capital expenditures is $5.89 million
Quarterly CFI-$57.20 M
TARO quarterly cash flow from investing activities is -$57.20 million

TARO Quarterly FCF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM FCF

$70.34 M
-$15.66 M-18.21%

31 March 2024

1-Year Change

-25.59%
TARO TTM free cash flow is down -25.59% year-on-year

3-Year Change

-2.08%
TARO TTM free cash flow is down -2.08% over the past 3 years

All-time High

$443.63 M
TARO TTM free cash flow is currently -84.15% below its historical high of $443.63 million
TTM CFO$124.56 M
TARO TTM cash flow from operations is $124.56 million
TTM CAPEX$54.22 M
TARO TTM capital expenditures is $54.22 million
TTM CFI$84.34 M
TARO TTM cash flow from investing activities is $84.34 million

TARO TTM FCF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TARO Free Cash Flow Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+490.9%-19.9%-25.6%
3 y3 years+145.8%+160.1%-2.1%
5 y5 years-76.0%-7.6%-72.8%

TARO Free Cash Flow High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years
5 y5 years
alltimeall time-82.5%-84.4%-84.1%

Taro Pharmaceutical Industries Free Cash Flow History

DateAnnualQuarterlyTTM
Mar 2024
$70.34 M(+490.9%)
$32.45 M(-1013.2%)
$70.34 M(-18.2%)
Dec 2023
-
-$3.55 M(-108.8%)
$86.00 M(-9.0%)
Sept 2023
-
$40.51 M(+4241.9%)
$94.52 M(+29.5%)
June 2023
-
$933.00 K(-98.1%)
$72.97 M(+513.1%)
Mar 2023
$11.90 M(-104.4%)
$48.11 M(+868.0%)
$11.90 M(-112.3%)
Dec 2022
-
$4.97 M(-73.8%)
-$97.03 M(-67.4%)
Sept 2022
-
$18.96 M(-131.5%)
-$297.23 M(-19.7%)
June 2022
-
-$60.14 M(-1.1%)
-$370.22 M(+37.1%)
Mar 2022
-$270.02 M(-1043.5%)
-$60.82 M(-68.8%)
-$270.02 M(+67.7%)
Dec 2021
-
-$195.24 M(+261.4%)
-$160.97 M(-324.1%)
Sept 2021
-
-$54.03 M(-234.8%)
$71.83 M(+635.2%)
June 2021
-
$40.07 M(-16.9%)
$9.77 M(-65.9%)
Mar 2021
$28.62 M(-88.2%)
$48.23 M(+28.4%)
$28.62 M(+30.5%)
Dec 2020
-
$37.56 M(-132.4%)
$21.94 M(-71.3%)
Sept 2020
-
-$116.09 M(-297.0%)
$76.31 M(-66.5%)
June 2020
-
$58.91 M(+41.8%)
$227.50 M(-6.5%)
Mar 2020
$243.19 M(-17.0%)
$41.55 M(-54.8%)
$243.19 M(-3.4%)
Dec 2019
-
$91.93 M(+161.9%)
$251.73 M(-2.6%)
Sept 2019
-
$35.10 M(-52.9%)
$258.34 M(-11.3%)
June 2019
-
$74.61 M(+48.9%)
$291.31 M(-0.6%)
Mar 2019
$293.02 M(-0.4%)
$50.09 M(-49.2%)
$293.02 M(-11.4%)
Dec 2018
-
$98.54 M(+44.7%)
$330.64 M(+5.6%)
Sept 2018
-
$68.08 M(-10.8%)
$313.21 M(+2.9%)
June 2018
-
$76.32 M(-13.0%)
$304.42 M(+3.5%)
Mar 2018
$294.15 M(-26.8%)
$87.71 M(+8.1%)
$294.15 M(-6.3%)
Dec 2017
-
$81.11 M(+36.8%)
$314.08 M(-11.2%)
Sept 2017
-
$59.28 M(-10.3%)
$353.63 M(-16.0%)
June 2017
-
$66.06 M(-38.6%)
$421.00 M(+4.8%)
Mar 2017
$401.71 M(+6.8%)
$107.63 M(-10.8%)
$401.71 M(-9.4%)
Dec 2016
-
$120.66 M(-4.7%)
$443.63 M(+3.9%)
Sept 2016
-
$126.65 M(+170.8%)
$426.97 M(+19.6%)
June 2016
-
$46.77 M(-68.7%)
$356.93 M(-5.1%)
Mar 2016
$376.02 M(-2.7%)
$149.56 M(+43.8%)
$376.02 M(-13.4%)
Dec 2015
-
$104.00 M(+83.7%)
$434.28 M(+2.6%)
Sept 2015
-
$56.61 M(-14.0%)
$423.47 M(+0.2%)
June 2015
-
$65.86 M(-68.3%)
$422.74 M(+9.3%)
Mar 2015
$386.63 M
$207.81 M(+123.0%)
$386.63 M(+49.9%)
Dec 2014
-
$93.19 M(+66.8%)
$258.00 M(-2.5%)
DateAnnualQuarterlyTTM
Sept 2014
-
$55.88 M(+87.8%)
$264.54 M(-12.1%)
June 2014
-
$29.75 M(-62.4%)
$301.08 M(-9.3%)
Mar 2014
$331.84 M(+39.2%)
$79.17 M(-20.6%)
$331.84 M(+2.1%)
Dec 2013
-
$99.73 M(+7.9%)
$324.93 M(+3.8%)
Sept 2013
-
$92.42 M(+52.7%)
$313.10 M(+11.2%)
June 2013
-
$60.51 M(-16.3%)
$281.51 M(+18.1%)
Mar 2013
$238.41 M(+211.7%)
$72.26 M(-17.8%)
$238.41 M(+43.5%)
Dec 2012
-
$87.90 M(+44.5%)
$166.15 M(+21.1%)
Sept 2012
-
$60.84 M(+249.6%)
$137.17 M(+0.1%)
June 2012
-
$17.41 M(-70.5%)
$137.05 M(-21.7%)
Mar 2012
$76.48 M(-56.3%)
-
-
Dec 2011
$175.11 M(+193.2%)
$58.92 M(-3.0%)
$175.11 M(+20.2%)
Sept 2011
-
$60.73 M(+89.8%)
$145.63 M(+54.1%)
June 2011
-
$32.00 M(+36.3%)
$94.48 M(+38.7%)
Mar 2011
-
$23.47 M(-20.3%)
$68.13 M(+14.1%)
Dec 2010
$59.73 M(+1.6%)
$29.44 M(+207.4%)
$59.73 M(+97.2%)
Sept 2010
-
$9.57 M(+69.5%)
$30.29 M(+46.2%)
June 2010
-
$5.65 M(-62.5%)
$20.72 M(+37.5%)
Mar 2010
-
$15.07 M
$15.07 M
Dec 2009
$58.77 M(-16.9%)
-
-
Dec 2008
$70.71 M(-1497.2%)
-
-
Dec 2007
-$5.06 M(-89.2%)
-
-
Dec 2006
-$46.97 M(+44.9%)
-
-
Dec 2005
-$32.42 M(-56.2%)
-
-
Dec 2004
-$74.08 M(-16.9%)
-
-
Dec 2003
-$89.16 M(+555.4%)
-
-
Dec 2002
-$13.60 M(-267.2%)
-
-
Dec 2001
$8.14 M(-240.0%)
-
-
Dec 2000
-$5.81 M(+28.8%)
-
-
Dec 1999
-$4.51 M(+32.6%)
-
-
Dec 1998
-$3.40 M(-45.2%)
-
-
Dec 1997
-$6.20 M(-18.4%)
-
-
Dec 1996
-$7.60 M(+85.4%)
-
-
Dec 1995
-$4.10 M(+32.3%)
-
-
Dec 1994
-$3.10 M(+19.2%)
-
-
Dec 1993
-$2.60 M(-63.4%)
-
-
Dec 1992
-$7.10 M(+222.7%)
-
-
Dec 1991
-$2.20 M
-
-

FAQ

  • What is Taro Pharmaceutical Industries annual free cash flow?
  • What is the all time high annual FCF for Taro Pharmaceutical Industries?
  • What is Taro Pharmaceutical Industries annual FCF year-on-year change?
  • What is Taro Pharmaceutical Industries quarterly free cash flow?
  • What is the all time high quarterly FCF for Taro Pharmaceutical Industries?
  • What is Taro Pharmaceutical Industries quarterly FCF year-on-year change?
  • What is Taro Pharmaceutical Industries TTM free cash flow?
  • What is the all time high TTM FCF for Taro Pharmaceutical Industries?
  • What is Taro Pharmaceutical Industries TTM FCF year-on-year change?

What is Taro Pharmaceutical Industries annual free cash flow?

The current annual FCF of TARO is $70.34 M

What is the all time high annual FCF for Taro Pharmaceutical Industries?

Taro Pharmaceutical Industries all-time high annual free cash flow is $401.71 M

What is Taro Pharmaceutical Industries annual FCF year-on-year change?

Over the past year, TARO annual free cash flow has changed by +$58.43 M (+490.92%)

What is Taro Pharmaceutical Industries quarterly free cash flow?

The current quarterly FCF of TARO is $32.45 M

What is the all time high quarterly FCF for Taro Pharmaceutical Industries?

Taro Pharmaceutical Industries all-time high quarterly free cash flow is $207.81 M

What is Taro Pharmaceutical Industries quarterly FCF year-on-year change?

Over the past year, TARO quarterly free cash flow has changed by -$8.06 M (-19.90%)

What is Taro Pharmaceutical Industries TTM free cash flow?

The current TTM FCF of TARO is $70.34 M

What is the all time high TTM FCF for Taro Pharmaceutical Industries?

Taro Pharmaceutical Industries all-time high TTM free cash flow is $443.63 M

What is Taro Pharmaceutical Industries TTM FCF year-on-year change?

Over the past year, TARO TTM free cash flow has changed by -$24.19 M (-25.59%)